Evaluation of an accelerated protocol for detection of extended-spectrum β-lactamase-producing gram-negative bacilli from positive blood cultures

Journal of Clinical Microbiology

Volumn 43, Issue 1, 2005, Pages 439-441

  Navon Venezia, Shiri ^a   Leavitt, Azita ^a   Ben Ami, Ronen ^a   Aharoni, Yuval ^a   Schwaber, Mitchell J ^a   Schwartz, David ^a   Carmeli, Yehuda ^a,b  

^a TEL AVIV UNIVERSITY   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; BETA LACTAMASE; CEFOTAXIME; CEFTAZIDIME; CLAVULANIC ACID; EXTENDED SPECTRUM BETA LACTAMASE; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ARTICLE; BACTERIUM DETECTION; BLOOD CULTURE; CITROBACTER; ENTEROBACTER; ENZYME ASSAY; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; INOCULATION; KLEBSIELLA; MORGANELLA MORGANII; NONHUMAN; PRIORITY JOURNAL; PROTEUS; PROVIDENCIA STUARTII; PSEUDOMONAS AERUGINOSA; SALMONELLA; SENSITIVITY AND SPECIFICITY; SERRATIA MARCESCENS; STENOTROPHOMONAS MALTOPHILIA;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; BLOOD; CEFOTAXIME; CEFTAZIDIME; CEPHALOSPORIN RESISTANCE; CULTURE MEDIA; GRAM-NEGATIVE BACTERIA; HUMANS; MICROBIAL SENSITIVITY TESTS; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY;

ACINETOBACTER; ACINETOBACTER BAUMANNII; BACILLI; BACTERIA (MICROORGANISMS); CITROBACTER; ENTEROBACTER; ESCHERICHIA COLI; KLEBSIELLA; MORGANELLA MORGANII; NEGIBACTERIA; PROVIDENCIA; PROVIDENCIA STUARTII; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA; SALMONELLA; SERRATIA MARCESCENS; STENOTROPHOMONAS; STENOTROPHOMONAS MALTOPHILIA;

EID: 11844283366     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.43.1.439-441.2005     Document Type: Article

References (12)

1. Bell, J. M., J. D. Turnidge, A. C. Gales, M. A. Pfaller, and R. N. Jones. 2002. Prevalence of extended-spectrum β-lactamase (ESBL)-producing clinical isolates in the Asia-Pacific region and South Africa: regional results from SENTRY Antimicrobial Surveillance Program (1998-99). Diagn. Microbiol. Infect. Dis. 42:193-198.
2. Carter, M. W., K. J. Oakton, M. Warner, and D. M. Livermore. 2000. Detection of extended-spectrum β-lactamases in klebsiellae with the Oxoid combination disk method. J. Clin. Microbiol. 38:4228-4232.
3. Harbarth, S., J. Garbino, J. Pugin, J. A. Romand, D. Lew, and D. Pittet. 2003. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am. J. Med. 115:529-535.
4. Jacoby, G. A., and A. A. Medeiros. 1991. More extended-spectrum β-lactamases. Antimicrob. Agents Chemother. 35:1697-1704.
5. Kollef, M. H. 2003. The importance of appropriate initial antibiotic therapy for hospital-acquired infections. Am. J. Med. 115:582-584.
6. Lautenbach, E., J. B. Patel, W. B. Bilker, P. H. Edelstein, and N. O. Fishman. 2001. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin. Infect. Dis. 32:1162-1171.
7. National Committee for Clinical Laboratory Standards. 2004. Performance standards for antimicrobial susceptibility testing. Fourteenth informational supplement. Approved standard M100-S14. National Committee for Clinical Laboratory Standards, Wayne, Pa.
8. Navon-Venezia, S., O. Hammer-Munz, D. Schwartz, D. Turner, B. Kuzmenko, and Y. Carmeli. 2003. Occurrence and phenotypic characteristics of extended-spectrum β-lactamases among members of the family Enterobacteriaceae at the Tel-Aviv Medical Center (Israel), and evaluation of diagnostic tests. J. Clin. Microbiol. 41:155-158.
9. Navon-Venezia, S., R. Ben-Ami, M. J. Schwaber, A. Leavitt, D. Schwartz, and Y. Carmeli. 2004. Protocol for accelerated detection of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae strains from blood cultures. Eur. J. Clin. Microbiol. Infect. Dis. 23:200-202.
10. Saurina, G., J. M. Quale, V. M. Manikal, E. Oydna, and D. Landman. 2000. Antimicrobial resistance in Enterobacteriaceae in Brooklyn, NY: epidemiology and relation to antibiotic usage patterns. J. Antimicrob. Chemother. 45:895-898.
11. Schwaber, M. J., P. M. Raney, J. K. Rasheed, J. W. Biddle, P. Williams, J. E. McGowan, Jr., and F. C. Tenover. 2004. Utility of NCCLS guidelines for identifying extended-spectrum β-lactamases in non-Escherichia coli and non-Klebsiella spp. of Enterobacteriaceae. J. Clin. Microbiol. 42:294-298.
12. Winokur, P. L., R. Canton, J. M. Casellas, and N. Legakis. 2001. Variations in the prevalence of strains expressing an extended-spectrum β-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region. Clin. Infect. Dis. 32(Suppl. 2):S94-S103.